Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2005 Feb;51(2):217-23.

Treatment of deep vein thrombosis: what factors determine appropriate treatment?

James D Douketis  1
Affiliations
Review

Treatment of deep vein thrombosis: what factors determine appropriate treatment?

James D Douketis. Can Fam Physician. 2005 Feb.

Abstract
in English, French

Objective: To identify patients with deep vein thrombosis (DVT) for whom in-hospital treatment should be considered.

Quality of evidence: The literature was searched for studies on outpatient treatment of DVT. Seventeen studies were assessed: seven were randomized controlled trials (level I evidence), and 10 were non-randomized trials (level II evidence).

Main message: Four criteria can be used to identify patients with DVT for whom outpatient treatment might not be appropriate: presence of massive DVT, presence of symptomatic pulmonary embolism, high risk of bleeding with anticoagulant therapy, and presence of comorbid conditions or other factors that warrant in-hospital care.

Conclusion: Four criteria can be used to identify patients with DVT for whom in-hospital treatment should be considered.

OBJECTIF: Identifier les cas de thrombose veineuse profonde (TVP) pour lesquels un traitement à l’hôpital devrait être envisagé.

QUALITÉ DES PREUVES: On a fouillé la littérature à la recherche d’études sur le traitement extra-hospitalier de la TVP. Dix-sept études ont été évaluées, dont 7 essais randomisés (preuves de niveau I) et 10 essais non randomisés (preuves de niveau II).

PRINCIPAL MESSAGE: On peut déterminer les cas de TVP pour lesquels un traitement extra-hospitalier risque d’être inapproprié en utilisant quatre critères : la présence d’une TVP massive, une embolie pulmonaire symptomatique, un haut risque d’hémorragie en cas de traitement anticoagulant et la présence d’un état de comorbidité ou d’autres facteurs requérant des soins hospitaliers.

CONCLUSION: Quatre critères peuvent être utilisés pour déterminer les cas de TVP pour lesquels un traitement à l’hôpital devrait être envisagé.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Care path for outpatient treatment of deep vein thrombosis
See this image and copyright information in PMC

Comment in

  • Nontreatment of deep vein thrombosis.
    Katz S, Rapoport-Glack S. Katz S, et al. Can Fam Physician. 2005 May;51(5):654; author reply 654-5. Can Fam Physician. 2005. PMID: 15934264 Free PMC article. No abstract available.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Tsai AW, Cushman M, Rosamund WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med. 2002;162(10):1182–1189. - PubMed
    1. Hanson PO, Welin L, Tibblin G, Eriksson H. Deep vein thrombosis and pulmonary embolism in the general population. “The Study of Men Born in 1913.”. Arch Intern Med. 1997;157(15):1665–1670. - PubMed
    1. Hyers TM, Agnelli G, Hull RD, Morris TA, Samama M, Tapson V, et al. Antithrombotic therapy for venous thromboembolic disease. Chest. 2001;119(Suppl 1):176–193. - PubMed
    1. Dolovich LR, Ginsberg JS, Douketis JD, Holbrook AM, Cheah G. A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency. Arch Intern Med. 2000;160(2):181–188. - PubMed
    1. Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS, Halperin JL, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanism of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119(Suppl 1):64–94. - PubMed